BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21235715)

  • 1. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
    Kassa J; Karasova JZ; Sepsova V; Caisberger F
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Bajgar J
    Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the reactivating and therapeutic efficacy of chosen combinations of oximes with individual oximes against VX in rats and mice.
    Kassa J; Karasova JZ; Sepsova V; Caisberger F; Bajgar J
    Int J Toxicol; 2011 Oct; 30(5):562-7. PubMed ID: 22013137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Musilek K; Horova A
    Toxicol Mech Methods; 2013 Feb; 23(2):94-8. PubMed ID: 22901042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of oxime mixtures to increase the reactivating and therapeutic efficacy of antidotal treatment of cyclosarin poisoning in rats and mice.
    Kassa J; Karasová JZ; Pavlíková R; Caisberger F; Bajgar J
    Acta Medica (Hradec Kralove); 2012; 55(1):27-31. PubMed ID: 22696932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova JZ; Musilek K; Kuca K
    Toxicol Mech Methods; 2009 Jun; 19(5):346-50. PubMed ID: 19778210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Musilek K; Horova A
    Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J; Kuca K; Cabal J; Paar M
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
    Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
    Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo.
    Bajgar J; Karasova JZ; Kassa J; Cabal J; Fusek J; Blaha V; Tesarova S
    Chem Biol Interact; 2010 Sep; 187(1-3):287-90. PubMed ID: 20167212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.